GATA3 and head and neck cancer: We further examined the expression of GATA3 in 10 matched primary-metastatic tumor samples from head and neck cancer patients, and the level of GATA3 was higher in the metastatic tumors (Fig. 7b, c and Supplementary Figure 5n).